Skip to main content
SY
NASDAQ Technology

So-Young International Reports Significant Net Losses, Declining Margins, and Confirms PFIC Status for 2025

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.78
Mkt Cap
$285.617M
52W Low
$0.741
52W High
$6.28
52W Position info
275% above low
Off High info
56% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

SY has more than doubled off its 52-week low of $0.741.

Summary

So-Young International reported a substantial net loss of RMB 242.3 million in 2025, following an even larger loss in 2024, alongside a significant drop in gross margin and continued negative operating cash flow, while also confirming its Passive Foreign Investment Company (PFIC) status for U.S. tax purposes.


Key Events · Earnings and Guidance · SY

  • Financial Performance Deterioration

    Reported a net loss of RMB 242.3 million (US$34.6 million) in 2025, following a RMB 589.5 million loss in 2024, a sharp decline from a net income of RMB 21.3 million in 2023.

  • Gross Margin Decline

    Gross margin significantly decreased to 47.8% in 2025 from 61.3% in 2024 and 63.7% in 2023.

  • Negative Operating Cash Flow

    Experienced negative cash flow from operating activities for the second consecutive year, reaching RMB 105.4 million (US$15.1 million) in 2025.

  • Goodwill Impairment

    Recorded a substantial goodwill impairment of RMB 540.0 million in 2024 related to the Wuhan Miracle acquisition, indicating underperformance of the acquired business.


Analysis · SY · Technology

The 20-F filing reveals a company facing significant financial headwinds, marked by consecutive net losses, a sharp decline in gross margins, and persistent negative operating cash flow. The substantial goodwill impairment in 2024 underscores challenges with past acquisitions. While the company is attempting to return capital to shareholders through dividends and share repurchases, these actions occur against a backdrop of deteriorating core profitability. The confirmed PFIC status for U.S. investors adds a material negative tax consideration. Investors should closely monitor the company's ability to reverse its profitability trends and generate positive cash flow from operations, especially given the competitive and evolving nature of the online medical aesthetic service industry in China.

At the time of this filing, SY was trading at $2.78 on NASDAQ in the Technology sector, with a market capitalization of approximately $285.6M. The 52-week trading range was $0.74 to $6.28. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SY - Latest Insights

SY
May 22, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.33
Real-time Price: $1.96 info
Change: -$0.370 (-16%) info
Market Cap: $196.746M info
SY
May 22, 2026, 5:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.46
Real-time Price: $1.96 info
Change: -$0.500 (-20%) info
Market Cap: $196.746M info
SY
Mar 25, 2026, 5:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.99
Real-time Price: $1.96 info
Change: -$1.03 (-34%) info
Market Cap: $196.746M info
SY
Mar 23, 2026, 8:51 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.96 info
Change: -$0.920 (-32%) info
Market Cap: $196.746M info
SY
Feb 13, 2026, 6:24 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $1.96 info
Change: -$1.64 (-46%) info
Market Cap: $196.746M info